共聚焦激光显微内镜预测克罗恩病患者术后复发的价值:一项先导研究
这项先导研究在25例克罗恩病回结肠切除术后6至12个月的患者中,比较白光内镜Rutgeerts评分与共聚焦激光显微内镜Watson分级的相关性,并对内镜下缓解者随访(中位38个月)。Rutgeerts评分与Watson评分显著相关(ρ=0.73,P<.0001),基线Watson评分在后续内镜复发者中显著更高(中位2.0 vs 1.0,P=.032)。
要点
- 共聚焦激光显微内镜Watson分级与Rutgeerts评分显著相关(ρ=0.73,P<.0001)。
- 基线Watson评分在后续内镜复发者中显著高于缓解者(中位2.0 vs 1.0,P=.032)。
- 基线Watson评分在临床复发者中显著高于临床缓解者(中位2.0 vs 1.0,P=.036)。
核心结论
- 共聚焦激光显微内镜可能有助于监测克罗恩病肠道切除术后患者,但需更大样本的进一步研究来证实这些初步结果。
研究设计与样本
- 先导研究连续纳入25例克罗恩病回结肠切除术后6至12个月的患者,行白光内镜(Rutgeerts评分)后行共聚焦激光显微内镜(Watson分级),仅对内镜下无复发(Rutgeerts i0和i1)者进行内镜和临床随访,中位随访38个月。
主要发现
- 首次术后结肠镜检查时,18例(72%)处于内镜下缓解,7例(28%)出现内镜复发(Rutgeerts ≥i2)。
- Rutgeerts评分与Watson评分显著相关(ρ=0.73,P<.0001)。
- 基线Watson评分在后续内镜复发患者中(中位2.0,四分位距1.5-2.0)显著高于内镜缓解患者(中位1.0,四分位距1.0-1.0;P=.032)。
- 基线Watson评分在临床复发患者中(中位2.0,四分位距2.0-2.0)显著高于临床缓解患者(中位1.0,四分位距1.0-1.0;P=.036)。
临床怎么用
- 原文结论认为共聚焦激光显微内镜可能有助于监测克罗恩病肠道切除术后患者,并指出需更大样本的进一步研究证实这些初步结果。
局限性
- 原文结论指出需更大样本的进一步研究来证实这些初步结果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Confocal laser endomicroscopy (CLE) has been shown to predict relapse in inflammatory bowel disease, but its value in the detection of postoperative recurrence in Crohn's disease (CD) is unknown. The aims of this pilot study performed in patients with CD after ileocolonic resection were to compare the macroscopic appearance of the neoterminal ileum, according to the endoscopic Rutgeerts score, with the microscopic findings provided by CLE 6 to 12 months after surgery and to assess the predictive values of CLE-generated parameters for predicting further recurrence in patients with postoperative endoscopic remission. METHODS: In 25 consecutive patients with CD within 6 to 12 months of surgery, the neoterminal ileum was examined by standard white-light endoscopy (Rutgeerts scale) followed by CLE (Watson grade). Only patients without endoscopic recurrence (Rutgeerts i0 and i1) were then followed endoscopically and clinically (median follow-up 38 months). RESULTS: At the time of the first postoperative colonoscopy, 18 patients (72%) were in endoscopic remission, and 7 (28%) experienced an endoscopic recurrence (Rutgeerts ≥i2). The Rutgeerts score was significantly correlated with the Watson score (ρ = 0 .73; P < .0001). The Watson scores at baseline were significantly higher in patients with further endoscopic recurrence (median 2.0; interquartile range [IQR] 1.5-2.0) than in those with endoscopic remission (median 1.0; IQR 1.0-1.0; P = .032) and were significantly higher in patients with clinical relapse (medium 2.0, IQR 2.0-2.0) compared with those in clinical remission (median 1.0; IQR 1.0-1.0; P = .036). CONCLUSIONS: CLE could be useful in monitoring patients with CD after intestinal resection. Further studies with a larger population are necessary to confirm these preliminary results.
引用
- Auzoux J, Boschetti G, Anon B, et al. Usefulness of confocal laser endomicroscopy for predicting postoperative recurrence in patients with Crohn's disease: a pilot study. Gastrointest Endosc. 2019. PMID: 30849396. doi:10.1016/j.gie.2019.02.030
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。